# A Phase II Open Label, Multi-Center Study With AVR118 in Anorectic Patients With Recurrent or Advanced Malignancies

> **NCT00765466** · PHASE2 · TERMINATED · sponsor: **McGill University** · enrollment: 30 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** AVR118

## Key facts

- **NCT ID:** NCT00765466
- **Lead sponsor:** McGill University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-10
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** Study transferred out of McGill because PI relocted to another insitution.
- **Last updated:** 2019-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00765466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00765466, "A Phase II Open Label, Multi-Center Study With AVR118 in Anorectic Patients With Recurrent or Advanced Malignancies". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00765466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*